|
ATCC
human epidermal melanocyte cell line pig1 ![]() Human Epidermal Melanocyte Cell Line Pig1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human epidermal melanocyte cell line pig1/product/ATCC Average 99 stars, based on 1 article reviews
human epidermal melanocyte cell line pig1 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
BioResource International Inc
cell line pig1 ![]() Cell Line Pig1, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cell line pig1/product/BioResource International Inc Average 90 stars, based on 1 article reviews
cell line pig1 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Oncology
Article Title: Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway
doi: 10.3389/fonc.2021.818178
Figure Lengend Snippet: The expression of lncRNA CD27-AS1-208, which locates in the nucleus, is increased during melanoma progression and significantly correlation with Ki-67 level. (A) Validation of differentially-expressed lncRNAs with a new cohort of samples. (B) The expression level of CD27-AS1-208 in melanocytes and melanoma cell lines. (C, D) The expression level of CD27-AS1-208 in the cytoplasm and nucleus of melanoma cells. (E) The location of CD27-AS1-208 in primary melanoma and nevus. (F) Immunofluorescence staining of Ki-67 in indicated melanoma tissues. (G) Correlation between CD27-AS1-208 level and Ki67 staining in melanoma tissue. * P < 0.05, ** P < 0.01, *** P < 0.001, NHEM or cytoplasm as control; # HMS as control, # P < 0.05, ## P < 0.01; & PIG1 as control, & P < 0.05, && P < 0.01. Scale bar = 10μm. ns., not significant.
Article Snippet: The immortalized normal
Techniques: Expressing, Biomarker Discovery, Immunofluorescence, Staining, Control